518
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Investigation of cancer cell lines for peptide receptor-targeted drug development

, , , , , & show all
Pages 719-730 | Received 28 Jul 2010, Accepted 11 Jan 2011, Published online: 10 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lichun Sun, Qingqing Qian, Guangchun Sun, L. Vienna Mackey, Joseph A. Fuselier, David H. Coy & Cui-Yun Yu. (2016) Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide–drug conjugate via activating somatostatin receptor type II. Journal of Drug Targeting 24:2, pages 169-177.
Read now
Paola Bonasoni, Jeannette Reyes, Sarah Keating, Ernest Cutz & Glenn Taylor. (2014) The Distribution and Frequency of Pulmonary Neuroendocrine Cells in Down Syndrome Fetal Lungs. Fetal and Pediatric Pathology 33:3, pages 157-165.
Read now

Articles from other publishers (10)

Jonas Lins, Yuliya A. Miloslavina, Stefania C. Carrara, Lorenz Rösler, Sarah Hofmann, Kevin Herr, Franziska Theiß, Laura Wienands, Olga Avrutina, Harald Kolmar & Gerd Buntkowsky. (2023) Parahydrogen-induced polarization allows 2000-fold signal enhancement in biologically active derivatives of the peptide-based drug octreotide. Scientific Reports 13:1.
Crossref
Marieta Elena Panait, Livia Chilug, Valentina Negoita, Antonela Busca, Gina Manda, Dana Niculae, Mirela Dumitru & Maria Iuliana Gruia. (2018) Biological Effects Induced by 68Ga-Conjugated Peptides in Human and Rodent Tumor Cell Lines. International Journal of Peptide Research and Therapeutics 25:3, pages 979-987.
Crossref
Servando Hernandez Vargas, Susanne Kossatz, Julie Voss, Sukhen C. Ghosh, Hop S. Tran Cao, Jo Simien, Thomas Reiner, Sadhna Dhingra, William E. Fisher & Ali Azhdarinia. (2019) Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery. Clinical Cancer Research 25:14, pages 4332-4342.
Crossref
Simon Lindner, Luise Fiedler, Björn Wängler, Peter Bartenstein, Ralf Schirrmacher & Carmen Wängler. (2018) Design, synthesis and in vitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC1-Receptors concomitantly overexpressed on various malignancies – Is the concept feasible?. European Journal of Medicinal Chemistry 155, pages 84-95.
Crossref
Nupur K. Purohit, Rashmi G. Shah, Samuel Adant, Michael Hoepfner, Girish M. Shah & Jean-Mathieu Beauregard. (2018) Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor. Oncotarget 9:37, pages 24693-24706.
Crossref
Paola Moreno, Samuel A. Mantey, Suk H. Lee, Irene Ramos-Álvarez, Terry W. Moody & Robert T. Jensen. (2018) A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3. Peptides 101, pages 213-226.
Crossref
Mahjabin Khan, Tao Huang, Cheng-Yuan Lin, Jiang Wu, Bao-Min Fan & Zhao-Xiang Bian. (2017) Exploiting cancer’s phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy. Oncotarget 8:61, pages 104615-104637.
Crossref
Alessia Di Florio, Veronica Sancho, Paola Moreno, Gianfranco Delle Fave & Robert T. Jensen. (2013) Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1833:3, pages 573-582.
Crossref
SALY HAFIZ, JOHN C. DENNIS, DEAN SCHWARTZ, ROBERT JUDD, YA-XIONG TAO, KAMEL KHAZAL, BENSON AKINGBEMI, XIU-LEI MO, ASIM B. ABDEL-MAGEED, EDWARD MORRISON & MAHMOUD MANSOUR. (2012) Expression of melanocortin receptors in human prostate cancer cell lines: MC2R activation by ACTH increases prostate cancer cell proliferation. International Journal of Oncology 41:4, pages 1373-1380.
Crossref
Laura G. Franko-TobinL. Vienna MackeyWei HuangXiangwei SongBaofeng JinJing LuoLynsie M. MorrisMinqiu Liu, Joseph A. FuselierDavid H. CoyLizi WuLichun Sun. (2012) Notch1-Mediated Tumor Suppression in Cervical Cancer with the Involvement of SST Signaling and Its Application in Enhanced SSTR-Targeted Therapeutics. The Oncologist 17:2, pages 220-232.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.